Together with the finding that in vitro incubation of recombinant scEMC10 could not improve motility of Emc10 KO spermatozoa, these results suggest that recombinant scEMC10 has limited therapeutic value for patients with asthenospermia. The gene discussed is EMC10; the disease is Reduced sperm motility.